Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

Characterization of Cembranoid Interaction with the Nicotinic Acetylcholine Receptor

Richard M. Hann, Oné R. Pagán, Liza Gregory, Tomas Jácome, Abimael D. Rodríguez, P. A. Ferchmin, Ruiliang Lu and Vesna A. Eterovic
Journal of Pharmacology and Experimental Therapeutics October 1998, 287 (1) 253-260;
Richard M. Hann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oné R. Pagán
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liza Gregory
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomas Jácome
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abimael D. Rodríguez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. A. Ferchmin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruiliang Lu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vesna A. Eterovic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The class of diterpenoids with a 14-carbon cembrane ring, the cembranoids, includes both competitive and noncompetitive inhibitors of the nicotinic acetylcholine receptor (AChR). All 20 coelenterate-derived cembranoids studied in this report inhibited [piperidyl-3,4-3H]-phencyclidine ([3H]-PCP) binding to its high-affinity site on the electric organ AChR, with IC50s ranging from 0.9 μM for methylpseudoplexaurate to 372 μM for lophotoxin. Inhibition was complete with all cembranoids but lophotoxin and most Hill coefficients were close to 1. Methylpseudoplexaurate and [3H]-PCP binding was competitive. Methylpseudoplexaurate and the fourth most potent cembranoid, eunicin, competed with each other for [3H]-PCP displacement, indicating that there exist one or more cembranoid sites on the AChR. Cembranoid affinity for the AChR correlated with hydrophobicity, but was also dependent on other features. Methylpseudoplexaurate and n-octanol also competed with each other for [3H]-PCP displacement, indicating that the cembranoid site is linked to the n-octanol site on the AChR. Unlike lophotoxin, the five cembranoids tested did not inhibit [125I]Tyr54-α-bungarotoxin binding to the AChR agonist sites. All seven cembranoids tested on oocyte-expressed electric organ AChR reversibly blocked acetylcholine-induced currents, although the inhibitor concentration curves were shallow and the inhibition was incomplete.

Footnotes

  • Send reprint requests to: Dr. Richard M. Hann, Department of Biochemistry and Center for Molecular and Behavioral Neuroscience, Universidad Central del Caribe, Box 60-327, Bayamón, PR 00960.

  • ↵1 This work was supported by Grants NIH-RCMI-2G12RR03035, NIH-MBRS-SO6GM50695 and NIH-RO1-GM52277. O.R.P. was a recipient of a Viets Fellowship from the Myasthenia Gravis Foundation of America.

  • ↵2 Current address: Center for Vaccine Development, University of Maryland School of Medicine, 685 W. Baltimore, Baltimore, MD 21202.

  • Abbreviations:
    AChR
    nicotinic acetylcholine receptor
    [3H]-PCP
    [piperidyl-3,4-3H]-phencyclidine
    [125I]-Bgt
    [125I]Tyr54-α-bungarotoxin
    ACh
    acetylcholine
    CCh
    carbamoylcholine
    DMSO
    dimethylsulfoxide
    HPTLC
    high-performance thin-layer chromatography
    Rf
    ratio of sample front to solvent front on HPTLC
    • Received March 17, 1998.
    • Accepted June 3, 1998.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 287, Issue 1
1 Oct 1998
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of Cembranoid Interaction with the Nicotinic Acetylcholine Receptor
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Characterization of Cembranoid Interaction with the Nicotinic Acetylcholine Receptor

Richard M. Hann, Oné R. Pagán, Liza Gregory, Tomas Jácome, Abimael D. Rodríguez, P. A. Ferchmin, Ruiliang Lu and Vesna A. Eterovic
Journal of Pharmacology and Experimental Therapeutics October 1, 1998, 287 (1) 253-260;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Characterization of Cembranoid Interaction with the Nicotinic Acetylcholine Receptor

Richard M. Hann, Oné R. Pagán, Liza Gregory, Tomas Jácome, Abimael D. Rodríguez, P. A. Ferchmin, Ruiliang Lu and Vesna A. Eterovic
Journal of Pharmacology and Experimental Therapeutics October 1, 1998, 287 (1) 253-260;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Antagonist-Induced Reversal of Functional and Structural Measures of Hippocampal Benzodiazepine Tolerance
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics